Delivery Order SPE2DB22D6029-SPE2DB24FLTCA
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,117.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of September 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of CEFPODOXIME 200 MG TABLET 20S. The $2,687.22 firm fixed price delivery order has a completion date of May 21, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DB22D1106 and SPE2DB24FEVJ1, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,856.90 firm fixed-price delivery order is for the procurement of 4564808969 - CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, valued at $2,156.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, with a period of performance through February 20, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,831.98 firm fixed-price delivery order is for the supply of 4567343227 CEFPODOXIME 200 MG TABLET 20S, with a period of performance through February 24, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, with an ID of SPE2DB20D3101 and SPE2DB25FRDB7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed-price delivery order is for the supply of 4567409254 CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 28, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.16, is a delivery order for the supply of 4567178201 CEFPODOXIME 200 MG TABLET 20S. It has an ultimate completion date of February 7, 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,291.45 firm fixed-price delivery order is for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary vehicle...
This federal contract award, valued at $3,555.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of February 20, 2025 and is a firm fixed-price contract. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp, the...
This federal contract award, with a GovTribe ID of SPE2DB22D3004|SPE2DB25FQQ09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,161.06 firm-fixed-price delivery order is for the supply of 4568180910 - CEFPODOXIME 200 MG TABLET 20S. The contract has a period of performance through May 9, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...